Health insurance company stops covering Truvada as PrEP

A national health insurance campany has announced that it will no longer cover the drug Truvada as pre-exposure prophylaxis (PrEP) to prevent contracting HIV. The insurance company, Assurant Health, have notified customers who had been taking Truvada (comprising the antiretrovirals tenofovir and emtricitabine) as PrEP, reports POZ.com. The insurer has stated that it would end…

Read More

New European studies show promise of HIV-prevention drug

Findings from two European studies on PrEP were released today at the Conference on Retroviruses and Opportunistic Infections in Seattle. The PROUD study out of England assesses the effect the use of PrEP has on the frequency with which men have sex, how often they use condoms, and whether they contract other sexually-transmitted infections. The…

Read More

Zachary Quinto responds to controversy over his OUT100 interview

Zachary Quinto has issued a response to the heated discussion generated by his OUT100 interview where he commented on the “complacency” of the gay community when it comes to the spread of HIV and the use of pre-exposure prophylaxis (PrEP). The debate has centered around the concept of monogamy within gay relationships and whether PrEP…

Read More

HRC endorses PrEP, calls for bold action to expand access to anti-HIV drug

WASHINGTON  — In a policy paper released Saturday, the Human Rights Campaign (HRC), explicitly endorsed the use of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is any medical or public health tool used to prevent the spread of a disease or infection prior to exposure. Truvada is the only brand name anti-HIV drug combination currently approved for…

Read More
CDC

New CDC guidelines recommend daily HIV prevention pill for those at substantial risk

Health care providers should consider advising the use of anti-HIV drugs by uninfected patients who are at substantial risk of infection, according to new clinical guidelines, released by Centers of Disease Control and Prevention (CDC). PrEP, or pre-exposure prophylaxis, could reduce HIV infection rates. When taken daily as directed, PrEP can reduce the risk of…

Read More